🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Sonida Senior Living, Inc. SNDA R2K

Healthcare · Medical Care Facilities · United States
https://www.sonidaseniorliving.com
Company Profile ↓
$40.02
+54.88% 1Y
Mkt Cap$1.89B
P/E-6.85
P/B1.85
52W High$42.21
52W Low$23.92
Book Value$18.95
EPS (TTM)$-5.84

Company Overview

Sonida Senior Living, Inc. owns and operates senior housing communities in the United States. The company provides independent living services, which include daily meals, transportation, social and recreational activities, laundry, housekeeping, and 24-hour staffing; and access to health screenings, periodic special services, and dietary and similar programs, as well as exercise and fitness classes. It offers assisted living services consist of personal care services, such as assistance with activities of daily living, including ambulation, bathing, dressing, eating, grooming, personal hygiene, and monitoring or assistance with medications; support services, such as meals, assistance with social and recreational activities, laundry, general housekeeping, maintenance, and transportation services; and supplemental services, which include extra transportation, personal maintenance, and extra laundry services, as well as special care services for residents with various forms of dementia. In addition, it offers memory care services; and home care services through third-party providers, such as customized physician, dentistry, podiatry, and other health-related rehabilitation and therapy services. Further, it provides respite care and temporary care and therapy programs. The company was formerly known as Capital Senior Living Corporation and changed its name to Sonida Senior Living, Inc. in November 2021. Sonida Senior Living, Inc. was founded in 1990 and is based in Dallas, Texas.

Why Investors Should Care

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $381.14M (+25.2% YoY); net profit $-70.78M.
  • Trailing 12 Months Year-on-year growth — revenue +38.5%.
  • 5-Year Trend Long-term compounding — revenue CAGR 4.4%.

Growth & Price Performance

Compounded Sales Growth

5 Years:4.38%
1 Year:38.50%

Stock Price Performance

1 Year:+54.88%
6 Months:+23.94%
3 Months:+20.72%
1 Month:+14.02%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 88% of range
$23.92 $42.21
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)58.25 · Neutral
Price Performance
1M+14.02%
3M+20.72%
6M+23.94%
1Y+54.88%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-6.85
Industry PE
25.41
Forward P/E
-90.95
PEG Ratio
2.04
Book Value
$18.95
Price to Book
1.85
P/S
4.52
EV/EBITDA
64.74
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
4.38%
Profit 5Y
-
Revenue (YoY)
38.50%
Earnings (YoY)
-

Profitability & Returns

ROCE
9.28%
ROE
-20.08%
ROA
-0.51%
Profit Margin
-27.08%
Op Margin
-3.03%
Gross Margin
25.01%
EPS (Latest Qtr)
$-2.39
EPS (TTM)
$-5.84

Balance Sheet & Liquidity

Debt/Equity
1.82
Quick Ratio
0.33
Current Ratio
0.44
Debt
$1.62B
Total Assets
$2.63B
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
9.89%
Chg in Prom Hold
0.04%
FII / Inst Holding
62.64%
Chg in FII Hold
-3.70%

Financial Snapshot

Enterprise Value
$1.89B
Total Revenue (TTM)
$367.34M
EBITDA
$49.08M
Free Cash Flow
$39.80M
Operating Cash Flow
$-15.35M
Shares Outstanding
47.35M
Gross Margin
25.01%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 SNDA Sonida Senior Living, Inc. R2K 40.02 -6.85 $1.89B 0.00% 9.28% -20.08% 4.38% -
2 LLY Eli Lilly and Company SPX 1,152.54 41.02 $1.03T 0.61% - 107.46% 7.20% 11.41%
3 JNJ Johnson & Johnson SPX 253.85 29.45 $611.07B 2.23% 14.88% 26.42% 2.43% 4.76%
4 ABBV AbbVie Inc. SPX 244.78 119.40 $432.48B 3.04% 10.47% -129.24% 1.75% -29.06%
5 UNH UnitedHealth Group Incorporated SPX 425.19 32.02 $386.13B 2.27% 9.74% 12.18% 10.40% 5.43%
6 MRK Merck & Co., Inc. SPX 120.78 34.02 $298.31B 2.86% - 18.94% 5.64% 10.01%
7 AZN AstraZeneca PLC NDX 164.50 24.81 $255.12B 1.77% 15.97% 23.48% 9.82% 45.96%
8 TMO Thermo Fisher Scientific Inc. SPX 534.07 29.33 $198.47B 0.40% 8.14% 13.52% 8.81% 12.95%
9 AMGN Amgen Inc. NDXSPX 355.25 24.69 $191.73B 2.84% 18.02% 101.32% 11.77% 5.58%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue ---------115.99M116.72M117.32M116.97M114.64M114.63M115.65M115.10M114.18M113.13M111.11M108.69M106.13M101.48M96.05M61.65M57.54M57.92M-------------
Operating Income -3.72M3.68M5.68M-4.15M5.79M3.69M--9.61M4.69M4.51M-5.39M3.64M1.70M-1.97M203.00K-8.11M-------------14.91M--20.14M---
Net Income -3.90M-6.04M-5.17M2.87M-5.95M-5.98M-4.45M-7.08M-10.51M-21.84M-7.83M-8.13M-6.36M-7.16M-9.06M-11.09M-26.29M-12.98M-12.53M-20.73M10.22M-47.18M-12.75M-214.96M38.84M49.08M36.51M-16.68M-7.41M-13.74M24.14M-12.21M-18.41M27.02M-9.82M-13.76M-12.53M-1.56M-26.91M-41.23M
Diluted EPS -0.13-0.21-0.180.10-0.21-0.21-0.15-0.24-0.36-750.00-270.00-280.00-220.00-0.24-0.30-0.37-0.88-0.43-0.41-0.680.34-23.28-6.25-104.9118.8023.4917.48-2.81-1.34-2.342.76-2.11-2.792.16-0.86-0.98-0.77-0.16-1.56-2.39

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 191.99M211.93M263.50M310.54M350.36M383.93M412.18M447.45M467.00M460.02M447.10M383.86M234.72M238.43M255.32M304.33M381.14M
Operating Income 16.61M18.52M17.91M13.65M11.25M13.90M18.84M14.39M7.84M7.60M-14.69M---57.90M68.67M-
Net Income 2.76M4.25M3.02M-3.12M-16.50M-24.13M-14.28M-28.02M-44.17M-53.60M-36.03M-295.37M125.61M-54.40M-21.11M-2.06M-70.78M
Diluted EPS 0.100.160.11-0.11-0.58-0.83-0.50-0.97-1.50-26.97-17.87-144.0837.92-9.27-3.85-0.54-4.22

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --382.78M462.33M636.94M745.55M891.37M1.02B1.15B1.18B1.15B1.27B702.83M728.55M661.27M621.46M841.92M844.85M
Total Equity 155.15M158.13M163.82M169.14M168.59M157.95M141.17M135.75M116.92M80.43M35.27M14.38M-279.26M-46.81M-101.71M-115.09M71.78M-11.00K
Cash & Equivalents 25.88M28.97M31.25M22.28M18.74M13.61M39.21M56.09M34.03M17.65M31.31M23.98M17.89M78.69M16.91M4.08M16.99M11.01M
Long Term Debt ------------604.73M613.34M625.00M587.10M635.90M682.45M
Total Liabilities ------------982.10M734.11M719.43M688.01M712.31M788.59M
Current Liabilities --32.40M40.21M62.15M58.70M99.46M70.54M81.39M87.00M85.03M129.03M373.12M120.48M94.32M100.86M75.61M105.13M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 19.64M15.55M14.08M46.40M42.64M52.28M55.59M36.87M5.23M-6.79M-28.80M-2.58M10.68M-1.78M24.36M
Investing Cash Flow -7.30M-5.28M-77.44M-190.62M-162.30M-201.05M-124.94M-21.91M47.78M8.51M-10.44M-36.90M-16.56M-208.92M-70.69M
Financing Cash Flow -9.24M-7.99M54.39M140.67M114.53M126.85M53.05M-1.67M-60.26M-15.92M99.42M-22.65M-7.11M232.04M37.51M
Capital Expenditure -----------10.44M-24.56M-17.94M-25.17M-33.28M
Free Cash Flow -----------39.24M-27.14M-7.25M-26.95M-8.92M
Share Buybacks 934.00K----2.50M---------

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -----------------
Operating Margin % 8.7%8.7%6.8%4.4%3.2%3.6%4.6%3.2%1.7%1.7%-3.3%---22.7%22.6%-
Net Margin % 1.4%2.0%1.1%-1.0%-4.7%-6.3%-3.5%-6.3%-9.5%-11.7%-8.1%-76.9%53.5%-22.8%-8.3%-0.7%-18.6%
ROE % 1.7%2.6%1.8%-1.9%-10.4%-17.1%-10.5%-24.0%-54.9%-152.0%-250.6%105.8%-268.3%53.5%18.3%-2.9%643,445.5%
ROCE % -5.3%4.2%2.4%1.6%1.8%2.0%1.4%0.7%0.7%-1.3%---11.1%9.0%-

Shareholding Pattern

Insiders
9.89%
Institutions
62.64%
Public Float
69.51%

Top Institutional Holders

#Holder% HeldSharesValue
1 Conversant Capital LLC 30.84% 14.61M $615.49M
2 Capital International Investors 3.68% 1.74M $73.47M
3 Irenic Capital Management LP 2.58% 1.22M $51.40M
4 Hazelview Securities Inc. 1.41% 668.65K $28.18M
5 J. Goldman & Co., L.P. 1.16% 550.68K $23.21M
6 Solas Capital Management, LLC 0.94% 445.88K $18.79M
7 Blackrock Inc. 0.90% 424.51K $17.89M
8 Vanguard Capital Management LLC 0.77% 363.74K $15.33M
9 Clayton Partners, LLC 0.66% 311.08K $13.11M
10 Jane Street Group, LLC 0.58% 273.43K $11.52M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SNDA

Google News ue, 14 Jul 2026

RBC Capital Raises its Price Target on Sonida (SNDA) - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQN2RqWWtNUHNqdlhqeEpSbjBtZ0F3ejlXRGhkTF9nWEctZkt1WV85cERnUVNPMXhzd0JmVTlSNFZiWHByaV9XZmFFNHdqbW9tRTFDOUpqOW0zaTBLY2VNc1VNMDJmM01PVmI0dDdCdE4yTVBJT0xrUEx2aS1HWU5zQ1R1MVJUdmJUZkFsQl…

Google News Mon, 13 Jul 2026

FDA starts full review of BioMarin’s VOXZOGO for children with achondroplasia - Stock Titan

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxPNkNYRWJMMnRReklOdjk5YjNxb19iSG5EQVZBNjhGRFp3ZThBZElpLUlyX3RiUXhyZTZVNVE0ZHE0bV9Nc2JQalplZzNSX1JrZkpPMXJRb2pwTjBnRzRGVldiYTFMNVZLR3B5OGxRVXR6VWo4bDlfV3FkRWl4TUhtMlp0OUlEX01abTA2M1…

Google News Fri, 10 Jul 2026

Avoiding Lag: Real-Time Signals in (SNDA) Movement - Stock Traders Daily

<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxOZmpER21QamlTQnNFRVBlT2E0WWVTdXhQRWVmLVBMMkp3NlZucndlRWNMZTI2a0NGekFubnp0b3ZRZHNWTHV6OElwQlFfY0pQblhpY0lnUi1VRTdTWTd1M1NnNmJPWUgxZm5YWHFvd21IekljdllVSWJEbTBkclVSYlVEdExJQUhJQTNWOV…

Google News Sat, 13 Jun 2026

Is Sonida Senior Living, Inc. (SNDA) A Good Stock To Buy Now? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxOaXFuVlJvbENCODVwV3paTWJubGMxLXRDeVZ1VlNnTmNnZjZ6aWROLXhSYTZ5bHdvUTQweHVXcVVqeGtxbFdCSlhwdGYtQUptX0ZkMUhhZDd0SDQxaUd3UklZSlNfcTYtTkdjZWdwSmRRRHd2SE5XN2hrTzdoalo5dzdvT3lzZWdnWlhXZ2…

Google News Sun, 29 Mar 2026

RBC Initiates Sonida Senior Living Stock With Outperform Rating, Predicting 24% Upside - TIKR.com

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNaUtjU05SR3Z6YnVxamd3NHBhNm5RUXhDOVF4cUk0cFhYRnowRFVtZU1uYlNWVFlQbzVsZGJ6Qmg1dDFxbnVfWHdRZkRSVGg4bFQ5VUpVZnJsekNHSDRUZWlBdDNZUDROZHFKaEJBSUQ1WXEzc1VkeTE3NjJNeXdFSUZweHZiblljdkhjWD…

Google News Mon, 11 May 2026

Sonida Senior Living Inc. (SNDA) Stock Rises on Q1 2026 Earnings - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxOWFpDbmhwUGRmb1h4dFlSLUJCT2NrRFd2VVlEWXM1aG53NE1QU3dHUU9qd2hBSmJkLWdfYXBhVFJCQ3VaX0xvZDdGeDZEMW9GWmk1akU3VnpxSEtGbk13a0k2Nl9naEZDTE55M0hob3FJbDd0Yjh6S015LVlVR0IzME9MQ1prd2x1X3dtQ1…

SNDA — Frequently Asked Questions

What is the current share price of Sonida Senior Living, Inc. (SNDA)?

As of 2026-07-14 21:23 PDT, Sonida Senior Living, Inc. (SNDA) trades at $40.02 on NYSE. Its 52-week range is $23.92 to $42.21.

What is the market capitalisation of SNDA?

Sonida Senior Living, Inc. (SNDA) has a market capitalisation of $1.89B on NYSE.

What is the P/E ratio of SNDA?

SNDA trades at a trailing price-to-earnings (P/E) ratio of -6.85. The industry average P/E is 25.41. Its price-to-book (P/B) ratio is 1.85.

What is the return on equity (ROE) of SNDA?

SNDA has a return on equity (ROE) of -20.08%. Its return on capital employed (ROCE) is 9.28%.

Is SNDA a good stock to buy?

This page provides a data-driven analysis of Sonida Senior Living, Inc. (SNDA), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space